Study of serum monocyte chemoattractant protein-1 as a marker of disease activity in rheumatoid arthritis patients

Study of Serum Monocyte Chemoattractant Protein-1AS A Marker in Rheumatoid Arthritis

Study of Serum Monocyte Chemoattractant Protein-1AS A Marker in Rheumatoid Arthritis

MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) IS ASSOCIATED WITH PANCREATIC BETA-CELL DYSFUNCTION IN TYPE 2 DIABETES MELLITUS

INTERLEUKIN-6 PROMOTER POLYMORPHISM (-174 G/C) IN EGYPTIAN PATIENTS WITH BEHCET's DISEASE

Molecular Detection of Monocyte Chemotactic Protein-1 gene Polymorphism in Patients with Spontaneous Bacterial Peritonitis

Genetic Polymorphisms of Monocyte Chemotactic Protein-1 and Risk of Spontaneous Bacterial Peritonitis in Post Hepatitis C Cirrhotic Patients

The study of polymorphism of the gene regulating region of the monocytechemoattractant protein-1 (MCP-1) insystemic lupus erythematosus

CORRELATION BETWEEN MONOCYTIC CHEMOTACTIC PROTEIN-1 (MCP-1) AND THE SEVERITY OF COVID-19 INFECTION.

Evaluation of Monocyte Chemoattractant Protein 1(MCP-1) as a Predictor of Complications in Type 2 Diabetes Mellitus in Zagazig University Hospital